RECENT NEWS
ACLA challenging US FDA’s ruling on laboratory-developed testing services
The American Clinical Laboratory Association (ACLA) and its member company, HealthTrackRx, have filed a lawsuit against the US Food and Drug Administration (FDA) in the United States District Court for the Eastern District of Texas, challenging the decision to regulate professional laboratory testing services as medical devices.
Indica Labs launches HALO update
Indica Labs has released updated versions of its life sciences software. The 4.0 versions of HALO, HALO AI, and HALO Link offer researchers and pathologists ease of use and performance, with even more opportunities to leverage advanced AI-powered image analysis in an open digital pathology ecosystem.
UKHSA investigating Escherichia coli outbreak
The UK Health Security Agency (UKHSA), together with public health agencies in Scotland, Northern Ireland and Wales, is investigating an increase in the number of Shiga toxin-producing E. coli (STEC) cases in the UK in recent weeks.
FDA authorisation for Roche’s four-in-one respiratory panel
Roche has announced today that the US Food and Drug Administration (FDA) has granted Emergency Use Authorisation (EUA) for its cobas Liat SARS-CoV-2, Influenza A/B and RSV nucleic acid test, an automated multiplex real-time polymerase chain reaction (RT-PCR) assay on the cobas Liat system.
Dreampath Diagnostics celebrates 10 years of the Fina system
The very first clinical installation of the Fina system for tissue block management took place 10 years ago at CHU Montpellier in France. The Fina system was developed as a solution to the problem of lost tissue samples in anatomic pathology (AP) laboratories. Thousands of tissue samples are lost in AP laboratories all over the world, and the impact can have devastating consequences for patients.
Quantifying antibody aggregation with an innovative new assay
Beckman Coulter Life Sciences has launched its new Valita Aggregation Pure assay, offering rapid, high-throughput protein aggregation detection and quantification, providing robust aggregation data in as little as 15 minutes.
London pathology services hit by ransomware attack
On Monday 3 June, Synnovis - which provides pathology services to Guy’s and St Thomas’ NHS Foundation Trust and King’s College Hospitals NHS Trust - was the victim of a ransomware cyberattack. All of Synnovis’ IT systems were affected, resulting in interruptions to many of its pathology services.
bioMérieux invests €9 million in new facility to combat AMR
bioMérieux inaugurated its new Rodolphe Mérieux Campus, in Bagno a Ripoli, Italy during May. The site includes a new R&D centre focusing on the fight against antimicrobial resistance, representing an investment of €9 million.
Ultra-sensitive blood test predicts recurrence of breast cancer
A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, London, used an ultra-sensitive liquid biopsy to detect the presence of tiny amounts of cancer DNA left in the body following treatment for early breast cancer.
Oxera report reveals value of biomedical scientists in NHS
A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways, the Institute of Biomedical Science (IBMS) has announced.
Study details potential of blood-based lung cancer screening
DELFI Diagnostics, a developer of blood-based AI tests that deliver a new way to enhance cancer detection, has announced the publication of a study examining the potential of its blood-based cancer screening, ‘Clinical validation of a cell-free DNA fragmentome assay for augmentation of lung cancer early detection’.
Sectra adds IT solution for genomics in cancer diagnostics
Sectra has launched a new diagnostic IT module for genomics within molecular pathology, developed in collaboration with the University of Pennsylvania Health System in the US.
IVDR updates adopted to help prevent shortages
The Council of the EU has formally adopted new rules updating the law on medical devices in order to help prevent shortages and ease the transition to greater transparency and access to information.
Sphere Fluidics accelerates cell line development workflows
Sphere Fluidics, a provider of innovative microfluidics-based solutions for single-cell analysis and isolation, has announced the launch of Cyto-Cellect PLUS. The new assay provides a rapid and cost-effective solution to quantify IgG production in single cells.
eLabNext unveils updated Sample and Inventory System
eLabNext has launched its new Sample and Inventory System, following a comprehensive overhaul which has been driven by extensive customer feedback and the firm’s commitment to enhancing usability, functionality, and integration.
POC test rapidly diagnoses Toxoplasma infections
An inexpensive, accurate test that detects infections with the parasite Toxoplasma gondii can provide results within 30 minutes from a finger-prick in a doctor’s office or within an hour from a small blood sample tested in a local medical laboratory.
NHS patients to access personalised cancer vaccine trials
Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS ‘matchmaking’ service to help find new life-saving treatments.
Paige launches Foundation Model service to support AI models
Digital pathology and AI firm Paige has announced the launch of a new service line based on its Foundation Models, including the world's largest multi-modal AI model in pathology and oncology.
WHO updates list of drug-resistant bacteria most threatening to human health
The World Health Organization (WHO) has released its updated Bacterial Priority Pathogens List (BPPL) 2024, featuring 15 families of antibiotic-resistant bacteria grouped into critical, high and medium categories for prioritisation. The list provides guidance on the development of new and necessary treatments to stop the spread of antimicrobial resistance (AMR).
Everything you need to know about NGS
INTEGRA Biosciences has released a new eBook providing a complete guide to next generation sequencing (NGS).
Latest Issues
Advanced Instruments has been a leading developer and manufacturer of analytical instruments and services for the clinical, biopharmaceutical, and food & beverage industries for more than 65 years. Globally, we provide innovative technologies aligned with the needs of the markets we serve, helping to improve efficiency, enhance productivity, and...
Pathology Visions 24
Hyatt Regency, Orlando, FL
3-5 November, 2025
UK NEQAS Cellular Pathology Technique - Annual Participant’s Meeting
America Square Conference Centre, London, EC3N 2LB.
4 - 5 November, 2024
Medica
Messe Dusseldorf
11-14 November, 2024
POCT-for-Scot: Bringing the future to you
SEC Arena, Glasgow
14 November, 2024
Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo
Hyatt Regency, Vancouver, Canada
19-23 November, 2024